Fusion Antibodies (FAB) RNS Announcements

Add to Alert list
Date Time Source Announcement
29 Apr 2019 02:46 PM
RNS
Director/PDMR Shareholding
25 Apr 2019 04:40 PM
RNS
Second Price Monitoring Extn
25 Apr 2019 04:35 PM
RNS
Price Monitoring Extension
18 Apr 2019 07:00 AM
RNS
Investor presentation
17 Apr 2019 07:00 AM
RNS
Trading Update
25 Feb 2019 07:00 AM
RNS
Trading Statement
21 Dec 2018 07:00 AM
RNS
Grant of Options
17 Dec 2018 07:00 AM
RNS
Launch of Rational Affinity Maturation Platform
03 Dec 2018 01:39 PM
RNS
Director/PDMR Shareholding
26 Nov 2018 07:00 AM
RNS
Half-year Report
19 Nov 2018 07:00 AM
RNS
Notice of Results
25 Sep 2018 02:23 PM
RNS
Director/PDMR Shareholding
24 Sep 2018 04:13 PM
RNS
Director/PDMR Shareholding
21 Sep 2018 11:24 AM
RNS
Result of AGM
28 Aug 2018 07:00 AM
RNS
Posting of Annual Report and Notice of AGM
16 Aug 2018 07:00 AM
RNS
Final Results
13 Aug 2018 07:00 AM
RNS
Trading Update
20 Jun 2018 01:06 PM
RNS
Ongoing discussions with MAB Discovery
24 May 2018 07:00 AM
RNS
Receipt of additional grants from Invest NI
09 May 2018 03:40 PM
RNS
Holding(s) in Company
23 Apr 2018 10:09 AM
RNS
Investor presentation
05 Mar 2018 07:00 AM
RNS
Trading Statement
01 Mar 2018 07:00 AM
RNS
Receipt of grants from Invest Northern Ireland
16 Jan 2018 10:06 AM
RNS
Director dealing
21 Dec 2017 09:35 AM
RNS
Holding(s) in Company
21 Dec 2017 09:33 AM
RNS
Holding(s) in Company
19 Dec 2017 07:00 AM
RNS
Holding(s) in Company
19 Dec 2017 07:00 AM
RNS
Holding(s) in Company
18 Dec 2017 08:00 AM
RNS
Admission to AIM and first day of dealings
10 Mar 2009 08:45 AM
RNS
Notice of De-Listing
02 Feb 2009 07:00 AM
RNS
Net Asset Value(s)
22 Dec 2008 04:21 PM
BZW
Rule 8.3 - Fabian Romania Ltd.
22 Dec 2008 04:16 PM
BZW
Rule 8.3 - Fabian Romania Ltd.
05 Dec 2008 07:00 AM
RNS
Change of Nominated Adviser's
11 Nov 2008 07:00 AM
RNS
Site Update
10 Nov 2008 12:02 PM
RNS
Holding(s) in Company
07 Nov 2008 04:56 PM
RNS
Holding(s) in Company
04 Nov 2008 10:59 AM
RNS
Holding(s) in Company
03 Nov 2008 10:31 AM
RNS
Holding(s) in Company
31 Oct 2008 06:27 PM
RNS
Statement re acquisition of s
30 Oct 2008 05:40 PM
RNS
Holding(s) in Company
27 Oct 2008 07:00 AM
RNS
Q3 Net Asset Value
29 Sep 2008 07:00 AM
RNS
Interim Results
24 Sep 2008 07:00 AM
RNS
Notice of Interim Results
30 Jul 2008 07:00 AM
RNS
Net Asset Value(s)
24 Jul 2008 07:00 AM
RNS
Result of AGM
26 Jun 2008 04:50 PM
RNS
Annual Report and Accounts
24 Jun 2008 07:00 AM
RNS
Final Results
17 Jun 2008 07:00 AM
RNS
Notice of Results
11 Jun 2008 07:00 AM
RNS
Acquisition

Fusion Antibodies is a biotechnology company that specializes in antibody development services for the healthcare industry. The company was founded in 2001 as a spin-out from Queen's University Belfast and is headquartered in Belfast, Northern Ireland. Fusion Antibodies offers antibody discovery, engineering, supply, and cell line development. It has developed proprietary technology platforms such as CDRx® for antibody humanization, RAMP® for affinity maturation, and ADD™ for developability optimization.

FAB share price launched at 165p in 2017.

UK 100

Latest directors dealings